# MOTS-c and muscle: atrophy, glucose uptake and CK2 in mice

Source: https://pepvault.app/research/mots-c-kumagai-2024

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [MOTS-c](https://pepvault.app/research#mots-c)

Animal study · mice

# MOTS-c prevented muscle atrophy, raised muscle glucose uptake in mice

Checked against the paper November 2026 Animal study [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In mice, MOTS-c's muscle effects seem to depend on CK2, and the human evidence here is a genetic link, not a treatment result.

- **Kind:** Animal study
- **Studied in:** Mice
- **Published:** 2024
- **Journal:** iScience

## What they tested

The team tested whether a protein called CK2 is the direct target that MOTS-c works through in skeletal muscle.

## How the study was done

A preclinical study that combined cell-free lab tests, mice given MOTS-c, and a look at people who naturally carry a MOTS-c variant called K14Q. The mouse work compared MOTS-c with and without CK2 activity held down.

<!--promo-->

PepVault for iPhone

## Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In mice, MOTS-c prevented skeletal muscle atrophy (muscle wasting) and boosted glucose uptake in muscle, and both effects were blunted when CK2 activity was suppressed. When given to mice by body-wide dosing, MOTS-c bound CK2 in both fat and muscle. It raised CK2 activity in muscle but lowered it in fat. The K14Q variant bound CK2 less, did not activate it, and did not produce the same effects. In people, men who carried K14Q had a higher risk of sarcopenia (age-related muscle loss) and type 2 diabetes, depending on age and physical activity, while women carriers had a lower type 2 diabetes risk at certain ages.

## What it doesn’t show

The muscle and glucose results come from mice and lab tests, not from people. The human part only looked at people who naturally carry a variant, so it shows a link and does not test what happens when someone takes MOTS-c.

## The paper

Kumagai et al. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience. 2024.

- [PubMed (PMID 39559755)](https://pubmed.ncbi.nlm.nih.gov/39559755/)
- [The paper (DOI 10.1016/j.isci.2024.111212)](https://doi.org/10.1016/j.isci.2024.111212)

## The compounds

- [MOTS-c: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/mots-c)
- [Dulaglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/dulaglutide)
- [MOTS-c dose guide](https://pepvault.app/lab/dosage/mots-c)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

## With this study

### MOTS-c

- [MOTS-c: the full reference](https://pepvault.app/peptides/mots-c)
- [MOTS-c dose guide](https://pepvault.app/lab/dosage/mots-c)

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Mixing charts

- [MOTS-c 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/mots-c-10mg)
- [MOTS-c 40 mg vial](https://pepvault.app/tools/reconstitution-calculator/mots-c-40mg)

### Studies

- [MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors](https://pepvault.app/research/mots-c-dieli-conwright-2021)
- [MOTS-c reduced islet cell senescence and glucose intolerance in mice](https://pepvault.app/research/mots-c-kong-2025)
- [MOTS-c eased lung ischemia-reperfusion injury and deaths in rats](https://pepvault.app/research/mots-c-li-2025)
- [All 9 studies](https://pepvault.app/research#mots-c)
- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022)
- [All 7 studies](https://pepvault.app/research#dulaglutide)

### Compared with

- [MOTS-c vs SS-31](https://pepvault.app/peptides/compare/mots-c-vs-ss-31)
- [MOTS-c vs SLU-PP-332](https://pepvault.app/peptides/compare/mots-c-vs-slu-pp-332)
- [NAD+ vs MOTS-c](https://pepvault.app/peptides/compare/nad-vs-mots-c)
- [Epitalon vs MOTS-c](https://pepvault.app/peptides/compare/epitalon-vs-mots-c)
- [MOTS-c vs Humanin](https://pepvault.app/peptides/compare/mots-c-vs-humanin)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on MOTS-c

- [MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors](https://pepvault.app/research/mots-c-dieli-conwright-2021) Randomized trial · people · 2021
- [MOTS-c reduced islet cell senescence and glucose intolerance in mice](https://pepvault.app/research/mots-c-kong-2025) Animal study · mice · 2025
- [MOTS-c eased lung ischemia-reperfusion injury and deaths in rats](https://pepvault.app/research/mots-c-li-2025) Animal study · rats · 2025
- [MOTS-c improved heart mitochondrial respiration in diabetic rats](https://pepvault.app/research/mots-c-pham-2025) Animal study · rats · 2025
- [MOTS-c raised testosterone, LH and FSH in obese and non-obese rats](https://pepvault.app/research/mots-c-ozturk-ozturk-2024) Animal study · rats · 2024
- [MOTS-c improved heart small-vessel barrier under endotoxin in mice](https://pepvault.app/research/mots-c-zou-2024) Animal study · mice · 2024
- [Every study on MOTS-c](https://pepvault.app/research#mots-c)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### MOTS-c

- [MOTS-c: the full reference](https://pepvault.app/peptides/mots-c)
- [MOTS-c dose guide](https://pepvault.app/lab/dosage/mots-c)

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Mixing charts

- [MOTS-c 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/mots-c-10mg)
- [MOTS-c 40 mg vial](https://pepvault.app/tools/reconstitution-calculator/mots-c-40mg)

### Studies

- [MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors](https://pepvault.app/research/mots-c-dieli-conwright-2021)
- [MOTS-c reduced islet cell senescence and glucose intolerance in mice](https://pepvault.app/research/mots-c-kong-2025)
- [MOTS-c eased lung ischemia-reperfusion injury and deaths in rats](https://pepvault.app/research/mots-c-li-2025)
- [All 9 studies](https://pepvault.app/research#mots-c)
- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022)
- [All 7 studies](https://pepvault.app/research#dulaglutide)

### Compared with

- [MOTS-c vs SS-31](https://pepvault.app/peptides/compare/mots-c-vs-ss-31)
- [MOTS-c vs SLU-PP-332](https://pepvault.app/peptides/compare/mots-c-vs-slu-pp-332)
- [NAD+ vs MOTS-c](https://pepvault.app/peptides/compare/nad-vs-mots-c)
- [Epitalon vs MOTS-c](https://pepvault.app/peptides/compare/epitalon-vs-mots-c)
- [MOTS-c vs Humanin](https://pepvault.app/peptides/compare/mots-c-vs-humanin)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on MOTS-c](https://pepvault.app/research#mots-c)

## The library

- [MOTS-c](https://pepvault.app/peptides/mots-c)
- [MOTS-c dose guide](https://pepvault.app/lab/dosage/mots-c)
- [Dulaglutide](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
